NEW YORK — The US Food and Drug Administration last week granted separate Emergency Use Authorizations (EUAs) for RT-PCR-based SARS-CoV-2 assays developed by Ultimate Dx, AIT Laboratories, and MicroGenDx.
NEW YORK — The US Food and Drug Administration last week granted separate Emergency Use Authorizations (EUAs) for RT-PCR-based SARS-CoV-2 assays developed by Ultimate Dx, AIT Laboratories, and MicroGenDx.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.